OBJECTIVES: Patients with mechanical circulatory support bridged to a heart transplant (HTx) are at higher risk of postoperative graft dysfunction. In this subset, a mode of graft preservation that shortens graft ischaemia should be beneficial. METHODS: The outcomes of 38 patients on mechanical circulatory support (extracorporeal life support, left ventricular assist device and biventricular assist device) who received a HTx between 2015 and 2020 were analysed according to the method of graft preservation: cold storage (CS) group, 24 (63%) or ex vivo perfusion (EVP) group, 14 (37%). RESULTS: The median age was 57 (range 30-73) vs 64 (35-75) years (P = 0.10); 88% were men (P = 0.28); extracorporeal life support was more frequent in the CS group (54% vs 36%; P = 0.27) versus left ventricular and biventricular assist devices in the EVP group (46% vs 64%; P = 0.27). Clamping time was shorter in the EVP group (P < 0.001) and ischaemic time >4 h was higher in the CS group (P = 0.01). Thirty-day mortality was 13% (0-27%) in the CS group and 0% (P = 0.28) in the EVP group. A significantly lower primary graft failure [7% (0-23%) vs 42% (20-63%); P = 0.03] was observed in the EVP group. Survival at 1 year was 79 ± 8% (63-95%) in the CS group and 84 ± 10% (64-104%) in the EVP group (P = 0.95). CONCLUSIONS: Our results support the use of ex vivo graft perfusion in patients on mechanical circulatory support as a bridge to a HTx. This technique, by shortening graft ischaemic time, seems to improve post-HTx outcomes.
OBJECTIVES: Patients with mechanical circulatory support bridged to a heart transplant (HTx) are at higher risk of postoperative graft dysfunction. In this subset, a mode of graft preservation that shortens graft ischaemia should be beneficial. METHODS: The outcomes of 38 patients on mechanical circulatory support (extracorporeal life support, left ventricular assist device and biventricular assist device) who received a HTx between 2015 and 2020 were analysed according to the method of graft preservation: cold storage (CS) group, 24 (63%) or ex vivo perfusion (EVP) group, 14 (37%). RESULTS: The median age was 57 (range 30-73) vs 64 (35-75) years (P = 0.10); 88% were men (P = 0.28); extracorporeal life support was more frequent in the CS group (54% vs 36%; P = 0.27) versus left ventricular and biventricular assist devices in the EVP group (46% vs 64%; P = 0.27). Clamping time was shorter in the EVP group (P < 0.001) and ischaemic time >4 h was higher in the CS group (P = 0.01). Thirty-day mortality was 13% (0-27%) in the CS group and 0% (P = 0.28) in the EVP group. A significantly lower primary graft failure [7% (0-23%) vs 42% (20-63%); P = 0.03] was observed in the EVP group. Survival at 1 year was 79 ± 8% (63-95%) in the CS group and 84 ± 10% (64-104%) in the EVP group (P = 0.95). CONCLUSIONS: Our results support the use of ex vivo graft perfusion in patients on mechanical circulatory support as a bridge to a HTx. This technique, by shortening graft ischaemic time, seems to improve post-HTx outcomes.
Authors: Mandeep R Mehra; Maria G Crespo-Leiro; Anne Dipchand; Stephan M Ensminger; Nicola E Hiemann; Jon A Kobashigawa; Joren Madsen; Jayan Parameshwar; Randall C Starling; Patricia A Uber Journal: J Heart Lung Transplant Date: 2010-07 Impact factor: 10.247
Authors: James K Kirklin; Francis D Pagani; Daniel J Goldstein; Ranjit John; Joseph G Rogers; Pavan Atluri; Francisco A Arabia; Anson Cheung; William Holman; Charles Hoopes; Valuvan Jeevanandam; Ranjit John; Ulrich P Jorde; Carmelo A Milano; Nader Moazami; Yoshifumi Naka; Ivan Netuka; Francis D Pagani; Salpy V Pamboukian; Sean Pinney; Joseph G Rogers; Craig H Selzman; Scott Silverstry; Mark Slaughter; John Stulak; Jeff Teuteberg; Juliane Vierecke; Stephan Schueler; David A D'Alessandro Journal: J Heart Lung Transplant Date: 2020-01-23 Impact factor: 10.247
Authors: Diana García Sáez; Bartlomiej Zych; Anton Sabashnikov; Christopher T Bowles; Fabio De Robertis; Prashant N Mohite; Aron-Frederik Popov; Olaf Maunz; Nikhil P Patil; Alexander Weymann; Timothy Pitt; Louise McBrearty; Bradley Pates; Rachel Hards; Mohamed Amrani; Toufan Bahrami; Nicholas R Banner; Andre R Simon Journal: Ann Thorac Surg Date: 2014-10-23 Impact factor: 4.330
Authors: Jon Kobashigawa; Andreas Zuckermann; Peter Macdonald; Pascal Leprince; Fardad Esmailian; Minh Luu; Donna Mancini; Jignesh Patel; Rabia Razi; Hermann Reichenspurner; Stuart Russell; Javier Segovia; Nicolas Smedira; Josef Stehlik; Florian Wagner Journal: J Heart Lung Transplant Date: 2014-03-05 Impact factor: 10.247